Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Apoptosis inducer shows promise in phase I trial in cancer patients

Sep. 30, 2004

Discovery of inhibitors of the MDM-p53 protein-protein interaction

Sep. 30, 2004

BCRP inhibitors and their use as drug resistance modulators described by Yakult Honsha

Sep. 30, 2004

Wyeth to manufacture Herceptin for Genentech

Sep. 30, 2004

ZD-4054 specifically inhibits ETA receptor-mediated antiapoptotic events

Sep. 29, 2004

Inhibition of Hsp90 in the treatment of SCLC

Sep. 29, 2004

PTK-787/ZK-222584 enhances antitumor activity of NVP-LAQ-824

Sep. 29, 2004

Canadian approval for phase I trial of Occlusin

Sep. 29, 2004

ECO-4601 shown to cross blood-brain barrier

Sep. 29, 2004

FDA Advisory Committee to review Marqibo in December

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...